14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.91 $2.54 Thursday, 2nd May 2024 CANF stock ended at $2.03. This is 2.87% less than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 9.44% from a day low at $2.01 to a day high of $2.20.
90 days $1.91 $2.71
52 weeks $1.81 $3.33

Historical Can-Fite BioPharma Ltd prices

Date Open High Low Close Volume
Sep 30, 2021 $1.69 $1.69 $1.63 $1.66 102 233
Sep 29, 2021 $1.69 $1.72 $1.66 $1.67 90 735
Sep 28, 2021 $1.67 $1.70 $1.64 $1.69 76 886
Sep 27, 2021 $1.68 $1.74 $1.66 $1.68 138 466
Sep 24, 2021 $1.66 $1.74 $1.65 $1.68 143 959
Sep 23, 2021 $1.68 $1.70 $1.65 $1.66 126 669
Sep 22, 2021 $1.65 $1.67 $1.65 $1.67 115 105
Sep 21, 2021 $1.71 $1.72 $1.65 $1.65 127 433
Sep 20, 2021 $1.69 $1.73 $1.68 $1.70 40 511
Sep 17, 2021 $1.73 $1.75 $1.71 $1.74 56 716
Sep 16, 2021 $1.72 $1.74 $1.70 $1.74 77 167
Sep 15, 2021 $1.73 $1.77 $1.71 $1.73 99 483
Sep 14, 2021 $1.77 $1.78 $1.72 $1.74 86 889
Sep 13, 2021 $1.76 $1.78 $1.75 $1.78 72 214
Sep 10, 2021 $1.80 $1.82 $1.75 $1.75 74 394
Sep 09, 2021 $1.79 $1.79 $1.76 $1.78 91 075
Sep 08, 2021 $1.80 $1.84 $1.75 $1.77 95 686
Sep 07, 2021 $1.83 $1.90 $1.78 $1.81 90 866
Sep 03, 2021 $1.78 $1.93 $1.76 $1.85 323 943
Sep 02, 2021 $1.89 $1.89 $1.71 $1.79 575 002
Sep 01, 2021 $1.85 $1.87 $1.84 $1.85 77 173
Aug 31, 2021 $1.84 $1.88 $1.84 $1.86 48 092
Aug 30, 2021 $1.89 $1.91 $1.81 $1.85 242 756
Aug 27, 2021 $1.87 $1.93 $1.86 $1.88 138 677
Aug 26, 2021 $1.83 $1.89 $1.83 $1.87 72 177
Click to get the best stock tips daily for free!

About Can-Fite BioPharma Ltd

Can-Fite BioPharma Ltd Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinical trial for the treatment of COVID-19. It also develops Namodenoson that is in Phase III clinical tria... CANF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT